The unglamourous AI wins that are quietly transforming drug discovery and development
The Hong Kong Genome Project is a flagship initiative for precision medicine in Chinese populations
Inside Interoception: The hidden sense of how you feel inside
The Download: “reprogramming” aging, and the hidden sense of interoception
Why “reprogramming” is the buzziest approach to reversing aging right now
Nvidia, Abridge collaborate to develop healthcare-specific AI model
Weekly Rundown: Karias Health launches AI companion; Mount Sinai, Wisp partner to expand PrEP access in NY
Industry Voices—Why health systems need physicians engaged in IT leadership
UnitedHealth, FTC reach proposed settlement in insulin case
Medicare Pays for Programs That May Not Help After Serious Hospitalizations
Five Things I Wish Someone Said at My 1998 Medical School Graduation
Optimism associated with decreased dementia risk
Where IME Documentation Breaks Traditional Healthcare Workflows
The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
Pancreatic Cancer Breakthrough: Experimental Combo Therapy Achieves 86% Survival Rate in Early Results
Home Care's AI Awakening: Stealth Startup Lands $6M to Bring Responsible Intelligence to an Overlooked Healthcare Sector
Alphabet's AI Scans Sewage at World Cup to Predict Disease Outbreaks Before Symptoms Emerge
Why Drug Trials Are About to Get Smarter: FDA Embraces Statistical Revolution That Could Save Years of Research
Pharma Giant Bets Half a Billion on Chip-Based Antibody Platform That Could Revolutionize Drug Hunting
FDA Approves Australian Blowfly Larvae to Devour Dead Tissue in Chronic Wounds
When Your Parent Refuses Assisted Living, Silicon Valley Steps In With 24/7 Surveillance
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
What Healthcare AI Can Learn From Vertical AI in Construction
The health AI industry's most durable companies will be those that go deepest in a single clinical domain — not the ones that build the most general-purpose platform. The success of vertical AI in adjacent industries offers a clear template.
OpenEvidence Launches Voice Mode and Closes $250M Series D at $12 Billion Valuation
OpenEvidence has launched a hands-free Voice Mode for its AI-powered medical search platform and disclosed a $250 million Series D round at a $12 billion valuation, backed by Google Ventures, Nvidia, Thrive Capital, and Mayo Clinic.
Europe's Clinical AI Market Faces a Reckoning as U.S. Platforms Pull Back
OpenEvidence's termination of access for UK and EU clinicians is not an isolated business decision — it reflects a deeper structural challenge facing European healthcare systems that have become dependent on U.S.-developed AI tools without building equivalent domestic capabilities.
The Network Is the New Bottleneck for Healthcare AI Infrastructure
The rapid deployment of clinical AI at the point of care is revealing a new constraint: the hospital data center and network infrastructure required to support real-time AI inference at scale. This analysis examines why infrastructure is the next frontier of the health AI buildout.
Tempus AI Reports 75% Revenue Growth in Q1 2026, Driven by Genomics and Data Licensing
Tempus AI has reported first-quarter 2026 revenue of $255 million, a 75% increase year-over-year, driven by strong growth in its genomics testing and data licensing segments as the company continues its post-IPO expansion.
Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical Foundation Model
Aidoc has closed a $150 million Series E round led by Goldman Sachs, with participation from existing investors, to scale its CARE clinical AI foundation model and expand its presence in radiology and emergency medicine workflows globally.
FDA Launches Elsa 4.0 and HALO Platform to Modernize Internal AI Capabilities
The FDA has launched Elsa 4.0 and the HALO (Health AI and Learning Operations) platform, consolidating the agency's internal AI and data infrastructure to accelerate regulatory reviews and modernize how the agency processes scientific evidence.
Innovaccer Acquires CaduceusHealth to Build Autonomous Revenue Cycle Management
Innovaccer has acquired CaduceusHealth for $66 million, combining its health data platform with CaduceusHealth's autonomous revenue cycle management capabilities to address the $265 billion annual cost of claim denials in U.S. healthcare.
Roche Acquires PathAI for $750 Million to Transform AI-Driven Pathology
Roche has agreed to acquire PathAI, the Boston-based digital pathology AI company, for approximately $750 million. The deal combines Roche's global diagnostics infrastructure with PathAI's FDA-cleared AI models for tissue analysis and biomarker identification.
Abridge Expands AI Nursing Platform to More Than 250 Health Systems
Abridge has announced general availability of Abridge for Nurses across its network of more than 250 health system partners, extending ambient AI documentation beyond physicians to the nursing workforce for the first time at scale.
Recursion Pharmaceuticals Advances Three AI-Discovered Drug Candidates Into Phase 2 Trials
Recursion Pharmaceuticals has announced that three drug candidates identified through its AI-powered drug discovery platform have advanced into Phase 2 clinical trials, marking a significant milestone for the AI-native pharmaceutical development model.
KFF Report Warns AI Could Exacerbate Racial Health Disparities Without Targeted Intervention
A new report from KFF (Kaiser Family Foundation) finds that AI systems deployed in clinical settings could widen existing racial and ethnic health disparities if not designed, validated, and monitored with equity as an explicit objective.
Ambient AI Reduces Open Charts by 90% at UToledo Health
UToledo Health has published results from its deployment of Nabla's ambient AI scribe, showing a reduction in open charts from more than 400 to under 30 — a 90% decrease — alongside measurable improvements in physician-patient connection scores.
Hippocratic AI Deploys Safety-Focused Health Agents Across 40 Health Systems
Hippocratic AI, the Palo Alto-based company building safety-focused AI health agents, has announced deployment across 40 health systems as its agents take on patient outreach, chronic disease management coaching, and post-discharge follow-up at scale.
Qventus Cuts OR Scheduling Inefficiency by 30% Across 60 Health Systems
Qventus, the AI-powered healthcare operations platform, has published results showing a 30% reduction in operating room scheduling inefficiency across its 60 health system clients, translating to significant revenue recovery from previously wasted surgical capacity.
Dexcom Stelo OTC Continuous Glucose Monitor Reaches One Million Users
Dexcom has announced that its Stelo continuous glucose monitor — the first OTC CGM approved by the FDA — has reached one million users, with the majority being people without diabetes who are using the device for metabolic health optimization.
Spring Health Raises $100 Million Series E to Expand AI-Matched Mental Health Benefits
Spring Health has closed a $100 million Series E funding round to expand its AI-powered mental health benefits platform, which uses machine learning to match employees with personalized care pathways and has reduced average time-to-first-appointment from 25 days to 2 days.
John Snow Labs Expands Healthcare NLP Platform to 500 Enterprise Clients
John Snow Labs has announced that its Spark NLP for Healthcare platform now serves more than 500 enterprise clients, making it the most widely deployed clinical NLP framework in the health AI industry.